Ghost Tree Capital, LLC Design Therapeutics, Inc. Transaction History

Ghost Tree Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$7.86 - $17.2 $134,775 - $294,928	-17,147 Reduced 17.15%	82,853 $850,000
Q3 2022 Nov 14, 2022	SELL	$14.09 - $25.57 $2.47 Million - $4.47 Million	-175,000 Reduced 63.64%	100,000 $1.67 Million
Q2 2022 Aug 15, 2022	BUY	$9.91 - $17.33 $743,250 - $1.3 Million	75,000 Added 37.5%	275,000 $3.85 Million
Q1 2022 May 16, 2022	BUY	$11.17 - $20.89 $726,050 - $1.36 Million	65,000 Added 48.15%	200,000 $3.23 Million
Q4 2021 Feb 16, 2022	BUY	$13.64 - $21.41 $1.84 Million - $2.89 Million	135,000 New	135,000 $2.89 Million

102

31M

2.3K

16.5K

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $347M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.